FHA
CSTL icon

First Horizon Advisors’s Castle Biosciences CSTL Stock Holding History

First Horizon Advisors’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$36.6K Sell
1,792
-18
-1% -$333 ﹤0.01% 1166
2025
Q1 		$36.2K Sell
1,810
-200
-10% -$4.95K ﹤0.01% 1075
2024
Q4 		$53.6K Sell
2,010
-60
-3% -$1.83K ﹤0.01% 920
2024
Q3 		$59K Sell
2,070
-5,783
-74% -$147K ﹤0.01% 913
2024
Q2 		$171K Hold
7,853
– – 0.01% 543
2024
Q1 		$174K Hold
7,853
– – 0.01% 537
2023
Q4 		$169K Sell
7,853
-250
-3% -$4.4K 0.01% 523
2023
Q3 		$137K Buy
8,103
+672
+9% +$11.8K 0.01% 551
2023
Q2 		$102K Buy
7,431
+442
+6% +$8.96K ﹤0.01% 639
2023
Q1 		$159K Buy
6,989
+18
+0.3% +$440 0.01% 523
2022
Q4 		$164K Sell
6,971
-257
-4% -$5.96K 0.01% 496
2022
Q3 		$188K Buy
7,228
+6,682
+1,224% +$187K 0.01% 450
2022
Q2 		$11K Sell
546
-52
-9% -$1.21K ﹤0.01% 1532
2022
Q1 		$27K Buy
598
+138
+30% +$5.7K ﹤0.01% 808
2021
Q4 		$19K Sell
460
-101
-18% -$5.28K ﹤0.01% 1294
2021
Q3 		$37K Buy
561
+179
+47% +$12.6K ﹤0.01% 1028
2021
Q2 		$28K Buy
382
+111
+41% +$7.33K ﹤0.01% 986
2021
Q1 		$18K Sell
271
-61
-18% -$4.58K ﹤0.01% 1105
2020
Q4 		$22K Buy
332
+149
+81% +$8.08K ﹤0.01% 863
2020
Q3 		$9K Buy
+183
New +$8.14K ﹤0.01% 1029

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

First Horizon Advisors's CSTL Position: Q2 2025 in Review

First Horizon Advisors reduced its Castle Biosciences (CSTL) stake by 0.99% in Q2 2025, selling an estimated $333 and leaving 1,792 shares worth $36.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

First Horizon Advisors first reported a position in CSTL in Q3 2020 and has held it in 20 quarters since. The position peaked at $188K in Q3 2022. 152 funds tracked by Wall St. Rank hold CSTL as of Q2 2025.

  • First Horizon Advisors held 1,792 shares of Castle Biosciences worth $36.6K as of Q2 2025.
  • First Horizon Advisors sold 18 Castle Biosciences shares in Q2 2025, an estimated $333.
  • Castle Biosciences made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1166 holding.
  • First Horizon Advisors first reported a position in Castle Biosciences in Q3 2020 and has held it in 20 quarters since.
  • First Horizon Advisors's Castle Biosciences position peaked at $188K in Q3 2022.
  • 152 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.